A deep tumor, without opening the skull

The problem. A woman in her early fifties begins to lose her peripheral vision: while driving, cars seem to "appear" out of nowhere. The MRI reveals a pituitary adenoma — a benign tumor at the geometric center of the head — compressing the optic chiasm, the crossing point of the nerves of vision. Benign does not mean harmless: untreated, the visual deficit progresses.

The alternatives. Three decades ago the discussion was different. Classic surgery meant a craniotomy: opening the skull and reaching the lesion by displacing the brain. It worked, but at a cost — brain retraction, weeks of recovery, a visible scar. Observation was not an option with vision at stake; medication works only in one specific subtype of these tumors.

The reasoning. The right question is not "how do I reach the tumor?" but "which route does the least harm to healthy tissue?". Anatomy offers an elegant answer: the pituitary sits just behind the nasal cavity, separated by a thin wall of bone. The nose is a natural corridor that leads exactly where the surgeon needs to go — without touching the brain.

The technology. A high-definition endoscope — a camera a few millimeters wide — enters through the nostril and lights up the anatomy in a detail the naked eye never had. Neuronavigation overlays the instruments' position onto the patient's MRI in real time, like a surgical GPS. The tumor is removed in fragments through the same corridor. There is no visible incision. The brain is never displaced.

The paradigm. The patient regains her visual field and goes home within days, not weeks. But what this case changed runs deeper than its outcome: it taught that the best surgery is not the one that best exposes the lesion, but the one that best respects everything else. The endonasal route is now the international standard for the vast majority of pituitary tumors, and its logic — choosing the corridor of least harm — has spread to the entire skull base.